✦ LIBER ✦

RAPIDLY ALTERNATING, DOSE-DENSE CHEMOTHERAPY AND RETROPERITONEAL LYMPH NODE DISSECTION (RPLND): OUTCOMES IN PATIENTS WITH HIGH-RISK NON-SEMINOMATOUS GERM CELL TUMOR

✍ Scribed by Kim, Philip H; Syan, Sumeet K.; Dorff, Tanya B.; Quinn, David; Skinner, Donald G.; Schuckman, Anne K.

Book ID: 123266080
Publisher: Lippincott Williams and Wilkins
Year: 2009
Tongue: English
Weight: 49 KB
Volume: 181
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(09)60569-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1118 Postchemotherapy retroperitoneal ly

1118 Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) including partial or complete resection of vertebral bodies in patients with non-seminomatous germ cell tumors (NSGCT)

✍ Zaum, M.; Lusch, A.; Lorch, A.; Winter, C.; Konieczny, M.; Senyurt, H.; Krauspe, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 111 KB

POST-CHEMOTHERAPY RETROPERITONEAL LYMPH

POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION CAN NOT BE SAFELY OMITTED IN PATIENTS WITH METASTATIC NON-SEMINOMATOUS GERM CELL TESTIS CANCER

✍ Nguyen, Carvell T; Subramanian, Vairavan S; Stephenson, Andrew J; Klein, Eric A 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 124 KB

RANDOMISED PHASE III TRIAL COMPARING RET

RANDOMISED PHASE III TRIAL COMPARING RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) WITH ONE COURSE OF BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP) CHEMOTHERAPY IN PATIENTS WITH STAGE I NON-SEMINOMATOUS GERM CELL TUMOUR PATIENTS (NSGCT) – UPDATED RESULTS OF AUO TRIAL 01/94

✍ P. Albers; R. Siener; S. Krege; H.U. Schmelz; K.P. Dieckmann; A. Heidenreich; P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB